The U.S. Patent and Trademark Office has issued the ’205 patent to Mawi DNA Technologies, covering its sample recovery and collection iSWAB technology.
iSWAB integrates a biosample collection and concentration device with a range of buffer formulations. Additionally, the technology stabilizes room temperature of DNA, RNA proteins and oral samples for drug screening.
The company specializes in noninvasive sample collection with an eye toward simplifying genomics and proteomics workflows. — Anisa Jibrell